Cryptocurrency News Official TheBitTimes.com

Shiba Inu was launched back in 2020 and has come a long way since inception. Within a short span of time, the project managed to create a loyal “army” of its own. The SHIB Army is quite vocal on social platforms like X [formerly Twitter], and Reddit. In fact, community members keep having regular discussions and constructive debates about every major and minor development. The asset’s price has also seen a steep incline over the years. From starting with almost two handfuls of “zeros” to knocking more than half of them out, SHIB has grown by leaps and bounds. When asked about the future, the My AI chatbot affirmed that exciting things lie ahead for Shiba Inu. Specifically, it pointed out that SHIB has managed to garner a lot of attention lately, and as a result, lucrative opportunities could be in the cards for the asset. Source: Chat Snapshot with My AI Chatbot Also Read: Shiba Inu: A $1,000 Investment Turns to $15 Million in Sept. 2023 What’s Next for SHIB? Ov...

InQubeta, an AI-based crowdfunding platform, is gaining attention as a potential competitor to ethereum (ETH), leading to a shift in investor sentiment . InQubeta introduces a crowdfunding platform that connects crypto investors with AI start-ups, creating a novel way for investors to participate in AI-driven projects. The platform’s fractional investment model, powered by its native token QUBE, provides investors with transparent and accessible access to the AI market. This approach has attracted retail investors previously limited in their investment options. While Ethereum has long been the leading smart contract platform, InQubeta is positioning itself as a contender. Focusing on the intersection of AI and blockchain, InQubeta brings new features that differentiate it from Ethereum. The project’s emphasis on AI technologies, a secure investment ecosystem, and strategic partnerships with AI start-ups make it an appealing alternative for investors seeking fresh op...

The Neuralink device is designed to be surgically implanted and, according to CEO Elon Musk, will eventually be marketed to the general public. Elon Musk’s brain -computer interface (BCI) startup, Neuralink, reportedly received approval from the United States Food and Drug Administration (FDA) to conduct some form of “in- human ” trials for its surgically implanted brain device.  Congratulations Neuralink team! https://t.co/AWZGf33UDr — Elon Musk (@elonmusk) May 26, 2023 It’s unclear at this time what kind of trials the Neuralink tweet is referring to — the only other information mentioned was that the company isn’t accepting applicants yet. Neuralink was denied the FDA’s approval for human trials in early 2022 over several concerns related to safety, which, at the time, the company was reportedly working to resolve. The FDA’s apparent U-turn would indicate that such concerns have been worked out, and the company should then be free to conduct limited testing of its sur...